2024 |
F5 Inc
|
Independent Director |
361.0 K |
- |
2024 |
Accolade Inc
|
Lead Independent Director |
262 K |
0.0 % |
2024 |
Denali Therapeutics Inc
|
Independent Director |
- |
- |
2024 |
Sarcos Technology and Robotics Corporation
|
Independent Director |
- |
- |
2023 |
Denali Therapeutics Inc
|
Independent Director |
439.4 K |
-6.1 % |
2023 |
F5 Inc
|
Independent Director |
350.0 K |
0.0 % |
2023 |
Accolade Inc
|
Lead Independent Director |
262 K |
10.5 % |
2023 |
F5 Inc
|
Independent Director |
- |
- |
2023 |
Sarcos Technology and Robotics Corporation
|
Independent Director |
- |
- |
2022 |
Denali Therapeutics Inc
|
Independent Director |
468.1 K |
13.4 % |
2022 |
F5 Inc
|
Independent Director |
350.0 K |
-0.0 % |
2022 |
Accolade Inc
|
Lead Independent Director |
237 K |
134.3 % |
2022 |
Sarcos Technology and Robotics Corporation
|
Independent Director |
209.0 K |
82.7 % |
2021 |
Denali Therapeutics Inc
|
Independent Director |
412.9 K |
2.6 % |
2021 |
F5 Inc
|
Independent Director |
350.1 K |
0.0 % |
2021 |
Sarcos Technology and Robotics Corporation
|
Independent Director |
114.4 K |
- |
2021 |
Accolade Inc
|
Lead Independent Director |
101.1 K |
-25.1 % |
2020 |
Denali Therapeutics Inc
|
Independent Director |
402.3 K |
-0.7 % |
2020 |
F5 Inc
|
Independent Director |
350.1 K |
2.6 % |
2020 |
Accolade Inc
|
Independent Director |
135 K |
- |
2020 |
Sarcos Technology and Robotics Corporation
|
Director |
- |
- |
2019 |
Denali Therapeutics Inc
|
Independent Director |
405.1 K |
-37.1 % |
2019 |
F5 Inc
|
Independent Director |
341.1 K |
3.4 % |
2018 |
Denali Therapeutics Inc
|
Independent Director |
643.8 K |
- |
2018 |
F5 Inc
|
Independent Director |
330.1 K |
-0.0 % |
2017 |
F5 Inc
|
Independent Director |
330.1 K |
0.0 % |
2017 |
Denali Therapeutics Inc
|
Independent Director |
- |
- |
2016 |
F5 Inc
|
Independent Director |
330.1 K |
12.1 % |
2015 |
F5 Inc
|
Independent Director |
294.5 K |
- |
2014 |
F5 Inc
|
Independent Director |
- |
- |